Hairloss treatments discussed include promising Pyr available online and Verteporfin dosing after FUE for follicle regeneration, but no updates on SCUBE3.
Hairloss treatments still rely heavily on minoxidil, finasteride, and RU58841, with little innovation. Future treatments like stem cell therapy and RNA technology show promise but are not yet available.
Exploring hairloss treatments beyond DHT, including Minoxidil, pyruvate, Gt20029 targeting androgen receptors, and vasodilators. Other options like Kx826, adenosine signaling, growth factor topicals, and microneedling are also discussed.
The post discusses a new hairloss treatment involving an improved pyri formula that has shown promising results, including thicker hair and a restored hairline, with minimal side effects. The author seeks investors to collaborate with Kintor or acquire the pyri patent, offering equity rewards and complimentary samples for verification.
Treatments for hairloss, focusing on Fluridil/Topilutamide (Eucapil), Finasteride and RU58841 (Alfatradiol). The user reported that the Fluridil seemed to work well but had side effects of testicle ache, decreased mood and sex drive.
Addressing hairloss by checking vitamin D and iron levels is crucial before adding more treatments. Supplementing these deficiencies can significantly reduce shedding.
Hairloss and potential treatments, primarily focusing on Finasteride and Minoxidil. Other solutions discussed include PRP, dermarolling, LLP, and scalp tension relief.
People are frustrated with the lack of new hairloss treatments stronger than minoxidil and finasteride. Some are using dutasteride to maintain hair while hoping for future solutions.
Hairloss treatments like minoxidil, finasteride, dutasteride, and RU58841. Users stress early prevention and discuss challenges with different hairloss patterns.
Hairloss treatments, including PP405, minoxidil, finasteride, and RU58841, with hopes for future solutions. Participants discuss the emotional impact of hairloss and consider alternatives like hair transplants or acceptance.
Hairloss treatments like minoxidil, finasteride, and dutasteride can stabilize hairloss and sometimes regrow hair, but many people still opt for hair transplants, often in Turkey, due to cost and convenience. However, transplants require ongoing medication to maintain results, and not all clinics offer high-quality outcomes.
Hairloss treatments have not advanced since 2018, with finasteride, minoxidil, and RU58841 still being the main options. A permanent cure is unlikely due to the profitability of ongoing treatments.
Hairloss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.
Hairloss in your 20s, with treatments like minoxidil, finasteride, dutasteride, and hair transplants discussed. Opinions vary between accepting baldness and pursuing aggressive treatments.
Hairloss is influenced by scalp tension, stress, and environmental factors, not just hormones. Treatments like tretinoin, microneedling, scalp massage, and Botox can reduce tension and improve hair health.
Hairloss affects self-esteem and mental health, with treatments like finasteride and minoxidil commonly used. People feel misunderstood by those without hairloss and seek more empathy and better treatment options.
New hairloss treatments like PP-405, AMP-303, and SCUBE3 are being discussed, but none are confirmed to fully restore hairlines. Current treatments like Minoxidil, Finasteride, and RU58841 are still widely used, with some hope for future advancements in hair regrowth.
Concerns about the potential systemic effects and safety of PP405 for hairloss, with discussions on its comparison to existing treatments like finasteride and minoxidil. Users express skepticism about untested research chemicals and emphasize the importance of clinical trials to ensure safety and efficacy.
Hairloss treatments like finasteride, minoxidil, and RU58841 are becoming more known, but many remain unaware of their effectiveness. There is hope for future advancements despite skepticism and misconceptions about current treatments.
PP405 is a new topical treatment for hairloss, showing promise in trials but still requires finasteride for maintenance. There is skepticism about its effectiveness and safety, with concerns about needing finasteride to maintain results.
Hairloss is a common issue, with treatments like finasteride and minoxidil used but not as permanent cures. Frustration exists over societal perceptions and the lack of a definitive solution.
Hairloss treatments like finasteride and minoxidil need time to work, often taking months. Patience and realistic expectations are crucial for success.
A 30-year-old man experienced significant hairloss after starting testosterone replacement therapy (TRT), which did not improve with daily finasteride and minoxidil. He is considering restarting TRT and is seeking advice on using pyrilutamide or RU58841 to prevent further hairloss.
Hairloss treatments discussed include Minoxidil, Finasteride, and RU58841. Anageninc stopped selling KX-826 (Pyrilutamide) due to a cease and desist letter from Kintor, but this may indicate promising study results and a potential 2024 release.
Hairloss treatments discussed include cosmeRNA, minoxidil, finasteride, RU58841, and pyrilutamide. Users debate effectiveness, side effects, and upcoming treatments, with some expressing skepticism and others optimism.
Hairloss discussion includes treatments like Minoxidil, Finasteride, and RU58841. User shares 3.5-month Dutasteride experience, slightly below baseline, with thicker hairs but less density.
Hairloss discussion mentions treatments like Finasteride, Dutasteride, and Minoxidil. Users share experiences, side effects, and advice on using these treatments.
Hairloss treatments discussed include Minoxidil, Finasteride, and RU58841. Users share experiences with Finasteride, mentioning watery semen as a side effect and weighing its importance against maintaining hair.